Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles. (Q47837030)

6 February 2018

title

Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles. (English)

1 reference

6 February 2018

author name string

Johnson JK

1

1 reference

6 February 2018

McCleary R

2

1 reference

6 February 2018

Oshita MH

3

1 reference

6 February 2018

Cotman CW

4

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

published in

Brain Research

1 reference

6 February 2018

volume

798

1 reference

6 February 2018

issue

1-2

1 reference

6 February 2018

page(s)

18-24

1 reference

6 February 2018

Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

beta-Amyloid converts an acute phase injury response to chronic injury responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Quantification of beta A4 protein deposition in the medial temporal lobe: a comparison of Alzheimer's disease and senile dementia of the Lewy body type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

MIXOR: a computer program for mixed-effects ordinal regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Cognitive skills associated with estrogen replacement in women with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E genotype and Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Alzheimer's disease, apolipoprotein E4, and gender.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E polymorphism and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Estrogen effects on cognition in menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Protection against Alzheimer's disease with apoE epsilon 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900363-1

10.1016/S0006-8993(98)00363-1

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9666062

1 reference

6 February 2018